Louis Pradel Hospital (Bâtiment A4)
Lyon, 69677, France
NCT Number: NCT01501578
This study is an observational and retrospective study of patients with pulmonary fibrosis associated or not with telomerase mutation.
The purpose of this study is to describe in detail the cases with telomerase mutation in terms of features on CT scan, respiratory function and evolution, in comparison to control subjects with idiopathic pulmonary fibrosis and no telomerase mutation identified or family history.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Lyon, 69677, France
Two "control" subjects will be enrolled for one subject with telomerase mutation.
The data are all the results of investigations conducted for the diagnosis of idiopathic pulmonary fibrosis and during routine follow up of patients.
The CT scans will reviewed centrally to homogenize the description.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: at baseline only
Description of imaging pattern on representative CT scan at diagnosis.
Time frame: at baseline only
description of pathological pattern
Time frame: from diagnosis to last follow-up, for an average of one year
analyze the respiratory function
Looking for future studies?
Notify MeGroupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires
Other
Phenotype of Pulmonary Fibrosis Associated With a Mutation of Telomerase
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07229716
Fibrosis, Lung Diseases
Xi’an, Shanxi, China
View Trial DetailsNCT06912659
Fibrosis, Lung Diseases
Barcelona, Spain
View Trial DetailsNCT07782060
Fibrosis, Lung Diseases
Belfast, Please Select, United Kingdom
View Trial DetailsNCT04619680
COVID-19, Cicatrix
Atlanta, Georgia, United States
View Trial Details